This may be responsible for the faster tumor progression and more aggressive disease seen in HIV-infected patients with HNSCC [29]; however, this needs to be confirmed in a larger study to see if HIV-positive patients with HN cancer may benefit from therapies targeting CXCR4. This evidence concerns the gene CXCR4 and neoplasm.